A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dioxaphetyl butyrate
Picosulfuric acid
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Picosulfuric acid.
Dioxaphetyl butyrate
Bisoxatin
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Bisoxatin.
Dioxaphetyl butyrate
Magnesium hydroxide
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium hydroxide.
Dioxaphetyl butyrate
Bisacodyl
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Bisacodyl.
Dioxaphetyl butyrate
Linaclotide
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Linaclotide.
Dioxaphetyl butyrate
Emodin
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Emodin.
Dioxaphetyl butyrate
Phenolphthalein
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Phenolphthalein.
Dioxaphetyl butyrate
Oxyphenisatin
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Oxyphenisatin.
Dioxaphetyl butyrate
Dantron
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Dantron.
Dioxaphetyl butyrate
Sorbitol
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Sorbitol.
Dioxaphetyl butyrate
Zinc
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Zinc.
Dioxaphetyl butyrate
Favipiravir
The serum concentration of Ertugliflozin can be increased when it is combined with Favipiravir.
Dioxaphetyl butyrate
Entrectinib
The serum concentration of Ertugliflozin can be increased when it is combined with Entrectinib.
Dioxaphetyl butyrate
Ivosidenib
The serum concentration of Ertugliflozin can be increased when it is combined with Ivosidenib.
Dioxaphetyl butyrate
ONT-093
The serum concentration of Ertugliflozin can be increased when it is combined with ONT-093.
Dioxaphetyl butyrate
Dexniguldipine
The serum concentration of Ertugliflozin can be increased when it is combined with Dexniguldipine.
Dioxaphetyl butyrate
Glecaprevir
The serum concentration of Ertugliflozin can be increased when it is combined with Glecaprevir.
Dioxaphetyl butyrate
Pibrentasvir
The serum concentration of Ertugliflozin can be increased when it is combined with Pibrentasvir.
Dioxaphetyl butyrate
Laniquidar
The serum concentration of Ertugliflozin can be increased when it is combined with Laniquidar.
Dioxaphetyl butyrate
Rucaparib
The serum concentration of Ertugliflozin can be increased when it is combined with Rucaparib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3